Cargando…

Acceptability of supervised injection facilities among persons who inject drugs in upstate New York

BACKGROUND: Supervised injection facilities (SIFs) provide spaces where persons who inject drugs (PWID) can inject under medical supervision and access harm reduction services. Though SIFs are not currently sanctioned in most of the US, such facilities are being considered for approval in several Up...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Eliana, Shufelt, Sarah, Barranco, Meredith, Udo, Tomoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338679/
https://www.ncbi.nlm.nih.gov/pubmed/35907854
http://dx.doi.org/10.1186/s12954-022-00665-x
_version_ 1784760024676958208
author Duncan, Eliana
Shufelt, Sarah
Barranco, Meredith
Udo, Tomoko
author_facet Duncan, Eliana
Shufelt, Sarah
Barranco, Meredith
Udo, Tomoko
author_sort Duncan, Eliana
collection PubMed
description BACKGROUND: Supervised injection facilities (SIFs) provide spaces where persons who inject drugs (PWID) can inject under medical supervision and access harm reduction services. Though SIFs are not currently sanctioned in most of the US, such facilities are being considered for approval in several Upstate New York communities. No data exist from PWID in Upstate New York, and little from outside major US urban centers, on willingness to use SIFs and associated factors. METHODS: This analysis included 285 PWID (mean age = 38.7; 57.7% male; 72.3% non-Hispanic white) recruited for a study on hepatitis C prevalence among PWID in Upstate New York, where participants were recruited from syringe exchange programs (n = 80) and able to refer other PWID from their injection networks (n = 223). Participants completed an electronic questionnaire that included a brief description of SIFs and assessed willingness to use SIFs. We compared sociodemographic characteristics, drug use/harm reduction history, healthcare experience, and stigma between participants who were willing vs. unwilling to use such programs. RESULTS: Overall, 67.4% were willing to use SIFs, 18.3% unwilling, and 14.4% unsure. Among those reporting being willing or unwilling, we found higher willingness among those who were currently homeless (91.8% vs. 74.6%; p = 0.004), who had interacted with police in the past 12 months (85.7% vs. 74.5%; p = 0.04), and who were refused service within a healthcare setting (100% vs. 77.1%; p = 0.03). CONCLUSION: Our results support SIF acceptability in several Upstate New York PWID communities, particularly among those reporting feelings of marginalization. A large proportion reported being unsure about usage of SIFs, suggesting room for educating PWID on the potential benefits of this service. Our results support SIF acceptability in Upstate New York and may inform programming for underserved PWID, should SIFs become available.
format Online
Article
Text
id pubmed-9338679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93386792022-07-31 Acceptability of supervised injection facilities among persons who inject drugs in upstate New York Duncan, Eliana Shufelt, Sarah Barranco, Meredith Udo, Tomoko Harm Reduct J Brief Report BACKGROUND: Supervised injection facilities (SIFs) provide spaces where persons who inject drugs (PWID) can inject under medical supervision and access harm reduction services. Though SIFs are not currently sanctioned in most of the US, such facilities are being considered for approval in several Upstate New York communities. No data exist from PWID in Upstate New York, and little from outside major US urban centers, on willingness to use SIFs and associated factors. METHODS: This analysis included 285 PWID (mean age = 38.7; 57.7% male; 72.3% non-Hispanic white) recruited for a study on hepatitis C prevalence among PWID in Upstate New York, where participants were recruited from syringe exchange programs (n = 80) and able to refer other PWID from their injection networks (n = 223). Participants completed an electronic questionnaire that included a brief description of SIFs and assessed willingness to use SIFs. We compared sociodemographic characteristics, drug use/harm reduction history, healthcare experience, and stigma between participants who were willing vs. unwilling to use such programs. RESULTS: Overall, 67.4% were willing to use SIFs, 18.3% unwilling, and 14.4% unsure. Among those reporting being willing or unwilling, we found higher willingness among those who were currently homeless (91.8% vs. 74.6%; p = 0.004), who had interacted with police in the past 12 months (85.7% vs. 74.5%; p = 0.04), and who were refused service within a healthcare setting (100% vs. 77.1%; p = 0.03). CONCLUSION: Our results support SIF acceptability in several Upstate New York PWID communities, particularly among those reporting feelings of marginalization. A large proportion reported being unsure about usage of SIFs, suggesting room for educating PWID on the potential benefits of this service. Our results support SIF acceptability in Upstate New York and may inform programming for underserved PWID, should SIFs become available. BioMed Central 2022-07-30 /pmc/articles/PMC9338679/ /pubmed/35907854 http://dx.doi.org/10.1186/s12954-022-00665-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Brief Report
Duncan, Eliana
Shufelt, Sarah
Barranco, Meredith
Udo, Tomoko
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
title Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
title_full Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
title_fullStr Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
title_full_unstemmed Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
title_short Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
title_sort acceptability of supervised injection facilities among persons who inject drugs in upstate new york
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338679/
https://www.ncbi.nlm.nih.gov/pubmed/35907854
http://dx.doi.org/10.1186/s12954-022-00665-x
work_keys_str_mv AT duncaneliana acceptabilityofsupervisedinjectionfacilitiesamongpersonswhoinjectdrugsinupstatenewyork
AT shufeltsarah acceptabilityofsupervisedinjectionfacilitiesamongpersonswhoinjectdrugsinupstatenewyork
AT barrancomeredith acceptabilityofsupervisedinjectionfacilitiesamongpersonswhoinjectdrugsinupstatenewyork
AT udotomoko acceptabilityofsupervisedinjectionfacilitiesamongpersonswhoinjectdrugsinupstatenewyork